Weiss Multi-Strategy Advisers’s Histogen Inc. Common Stock HSTO Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio HSTO Stock Details HSTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-58	Closed	-$66K	–	685
2017 Q1	$66K	Buy	+58	New	+$56K	﹤0.01%	532
2015 Q2	–	Sell	-350	Closed	-$498K	–	555
2015 Q1	$498K	Sell	350 -175	-33%	-$222K	0.02%	365
2014 Q4	$735K	Hold	525	–	–	0.03%	306
2014 Q3	$643K	Hold	525	–	–	0.02%	425
2014 Q2	$957K	Buy	525 +50	+11%	+$66.8K	0.02%	424
2014 Q1	$773K	Sell	475 -300	-39%	-$627K	0.02%	550
2013 Q4	$1M	Sell	775 -225	-23%	-$359K	0.02%	437
2013 Q3	$2.01M	Buy	+1,000	New	+$1.86M	0.04%	341

Other funds holding HSTO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Weiss Multi-Strategy Advisers's HSTO Position: Q2 2017 in Review

Weiss Multi-Strategy Advisers sold out of Histogen Inc. Common Stock (HSTO) in Q2 2017, closing a stake of 58 shares — an estimated $66K sold.

Weiss Multi-Strategy Advisers first reported a position in HSTO in Q3 2013 and held it in 8 quarters. The position peaked at $2.01M in Q3 2013. 70 funds tracked by Wall St. Rank hold HSTO as of Q2 2017.

Weiss Multi-Strategy Advisers reported no remaining Histogen Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 58 Histogen Inc. Common Stock shares in Q2 2017, an estimated $66K.
Weiss Multi-Strategy Advisers first reported a position in Histogen Inc. Common Stock in Q3 2013 and held it in 8 quarters.
Weiss Multi-Strategy Advisers's Histogen Inc. Common Stock position peaked at $2.01M in Q3 2013.
70 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2017.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2017, filed 14 Aug 2017.